Rainbow Childrens Medicare Ltd (RAINBOW) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1003646,
    "name": "Rainbow Child.",
    "stock_name": "Rainbow Child.",
    "full_name": "Rainbow Childrens Medicare Ltd",
    "name_url": "stocks-analysis/rainbow-child",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,114.55",
    "chg": -34.75,
    "chgp": "-3.02%",
    "dir": -1,
    "prev_price": "1,149.30",
    "mcapval": "11,707.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 543524,
    "symbol": "RAINBOW",
    "ind_name": "Hospital",
    "ind_code": 94,
    "indexname": "",
    "isin": "INE961O01016",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "4.56 lacs",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/rainbow-child-1003646-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Rainbow Child. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-rainbow-child-technically-bullish-or-bearish-3740815",
        "imagepath": "",
        "date": "2025-12-02 09:41:13",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Trend Shift and Price Action</strong></p>\n<p>As of 1 December 2025, Rainbow Child.'s technical trend has shifted from bearish to mildly bearish. This subtle change indicates that while the stock remains under pressure, the intensity of the downtrend has somewhat eased. The current price stands at ₹1,334.85, down from the previous close of ₹1,360.05, reflecting a short-term decline. The stock’s 52-week range spans from ₹1,205.65 to ₹1,701.40, placing the current price closer to the lower end of this spectrum, which may suggest limited downside room but also highlights recent weakness.</p>\n<p><strong>Technical Indicators: A Mixed Bag</strong></p>\n<p>Examining the key technical indicators provides a nuanced view. The Moving Average Convergence Divergence (MACD) remains bearish on the wee..."
      },
      {
        "title": "Rainbow Childrens Medicare: Technical Momentum and Market Assessment Update",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/rainbow-childrens-medicare-sees-mixed-technical-signals-amid-price-momentum-shift-3740432",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/RainbowChildren_technicaldot_3740432.png",
        "date": "2025-12-02 08:12:38",
        "description": "Rainbow Childrens Medicare has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bearish and bullish signals across multiple timeframes. This article analyses the recent changes in key technical indicators and places the stock’s performance in the context of broader market trends."
      },
      {
        "title": "Rainbow Childrens Medicare Faces Technical Momentum Shift Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/rainbow-childrens-medicare-faces-bearish-technical-momentum-amid-mixed-signals-3737555",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/RainbowChildren_technicaldot_3737555.png",
        "date": "2025-12-01 08:05:04",
        "description": "Rainbow Childrens Medicare, a key player in the hospital sector, is exhibiting a notable shift in its technical momentum as recent evaluation adjustments reflect a transition from mildly bearish to bearish trends. This development comes amid a complex interplay of technical indicators, including MACD, RSI, and moving averages, which collectively paint a nuanced picture of the stock’s near-term trajectory."
      },
      {
        "title": "Rainbow Childrens Medicare Sees Mixed Technical Signals Amid Market Shifts",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/rainbow-childrens-medicare-sees-mixed-technical-signals-amid-price-momentum-shift-3734753",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/RainbowChildren_technicaldot_3734753.png",
        "date": "2025-11-28 08:08:02",
        "description": "Rainbow Childrens Medicare has experienced a nuanced shift in its technical indicators, reflecting a complex momentum landscape as the stock navigates recent market conditions. While some weekly signals suggest emerging bullish tendencies, monthly trends and moving averages indicate a cautious stance for investors in the hospital sector."
      },
      {
        "title": "Rainbow Child. Sees Revision in Market Evaluation Amid Mixed Financial Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/rainbow-child-downgraded-to-sell-by-marketsmojo-amid-valuation-and-technical-concerns-3733241",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/RainbowChild_mojoScore_3733241.png",
        "date": "2025-11-27 10:05:37",
        "description": "Rainbow Child., a small-cap player in the hospital sector, has experienced a revision in its market evaluation reflecting a shift in analytical perspective. This adjustment follows a detailed review of the company’s financial trends, valuation, quality, and technical outlook, highlighting challenges in long-term growth and market performance despite certain positive financial indicators."
      },
      {
        "title": "Rainbow Childrens Medicare Q2 FY26: Strong Quarterly Rebound Masks Valuation Concerns",
        "link": "https://www.marketsmojo.com/news/result-analysis/rainbow-childrens-medicare-q2-fy26-strong-quarterly-rebound-masks-valuation-concerns-3718494",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/RainbowChildren_quaterlyResult_3718494.png",
        "date": "2025-11-15 11:00:17",
        "description": "Rainbow Childrens Medicare Ltd., India's specialised paediatric and multispecialty hospital chain, delivered a robust operational performance in Q2 FY26, with consolidated net profit surging 40.65% quarter-on-quarter to ₹75.25 crores. However, the year-on-year picture remains subdued, with profits declining 4.59% from ₹78.87 crores in Q2 FY25, raising questions about sustainable growth momentum. The stock, currently trading at ₹1,339.95 with a market capitalisation of ₹13,614 crores, has declined 1.08% following the results announcement, reflecting investor caution despite the sequential improvement."
      },
      {
        "title": "How has been the historical performance of Rainbow Child.?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-rainbow-child-3704160",
        "imagepath": "",
        "date": "2025-11-15 00:27:13",
        "description": "Answer:\nThe historical performance of Rainbow Child shows a consistent growth trend across various financial metrics over the past six years.\n\nBreakdown:\nRainbow Child's net sales have increased significantly from 650.05 Cr in Mar'21 to 1,515.87 Cr in Mar'25, reflecting a strong upward trajectory. Total operating income followed a similar trend, rising from 719.39 Cr in Mar'20 to 1,515.87 Cr in Mar'25. The company's operating profit (PBDIT) also saw substantial growth, climbing from 173.10 Cr in Mar'21 to 540.90 Cr in Mar'25, although the operating profit margin slightly decreased from 33.07% in Mar'24 to 32.32% in Mar'25. Profit before tax rose from 55.70 Cr in Mar'21 to 330.00 Cr in Mar'25, while profit after tax increased from 39.57 Cr in Mar'21 to 244.23 Cr in Mar'25, showcasing improved profitability. The total assets of the company grew from 1,018.89 Cr in Mar'20 to 2,347.40 Cr in Mar'25, indicating a..."
      },
      {
        "title": "How has been the historical performance of Rainbow Child.?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-rainbow-child-3699750",
        "imagepath": "",
        "date": "2025-11-13 23:48:54",
        "description": "Answer:\nThe historical performance of Rainbow Child shows a consistent growth trajectory over the years.\n\nBreakdown:\nRainbow Child's net sales have increased significantly from INR 650.05 crore in March 2021 to INR 1,515.87 crore in March 2025, reflecting a strong upward trend. Total operating income followed suit, rising from INR 719.39 crore in March 2020 to the same INR 1,515.87 crore in March 2025. The company's operating profit (PBDIT) also saw substantial growth, climbing from INR 173.10 crore in March 2021 to INR 540.90 crore in March 2025. Profit before tax rose from INR 55.70 crore in March 2021 to INR 330.00 crore in March 2025, while profit after tax increased from INR 39.57 crore to INR 244.23 crore during the same period. The earnings per share (EPS) improved from INR 7.29 in March 2021 to INR 23.97 in March 2025, indicating enhanced shareholder value. On the balance sheet, total assets grew fr..."
      },
      {
        "title": "Are Rainbow Child. latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-rainbow-child-latest-results-good-or-bad-3698409",
        "imagepath": "",
        "date": "2025-11-13 19:38:43",
        "description": "Rainbow Childrens Medicare has announced its financial results for the quarter ending June 2025, which reflect a mix of operational trends. The company reported an annual operating cash flow of Rs 385.05 crore, marking the highest level in the last three years, indicating a positive trend in cash revenues from its business operations. Additionally, the debt-equity ratio improved to 0.52 times, the lowest in the last five half-year periods, suggesting a reduction in borrowing relative to equity capital. The company also declared a dividend per share of Rs 3.00, the highest in five years, demonstrating a commitment to returning profits to shareholders.\n\nHowever, the results also highlight some challenges. Profit Before Tax (PBT) fell by 26.4% to Rs 51.35 crore, and Profit After Tax (PAT) decreased by 12.1% to Rs 53.50 crore, indicating negative trends compared to previous quarters. Net sales also declined by ..."
      }
    ],
    "total": 257,
    "sid": "1003646",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/rainbow-childrens-medicare-1003646"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
      "datetime": "29-Jan-2026",
      "details": "Audio Recording of Conference Call with Investors/ Analysts for Q3 & 9M FY26 results.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "29-Jan-2026",
      "details": "Newspaper Advertisement",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
      "datetime": "28-Jan-2026",
      "details": "Earnings Presentation on Unaudited Financial Results (Standalone and Consolidated) for the Quarter and Nine months ended December 31 2025.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Rainbow Childrens Medicare Ltd has declared <strong>30%</strong> dividend, ex-date: 27 Jun 25",
          "dt": "2025-06-27",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Is Rainbow Child. technically bullish or bearish?

2025-12-02 09:41:13

Recent Trend Shift and Price Action As of 1 December 2025, Rainbow Child.'s technical trend has shifted from bearish to mildly bearish. This subtle change indicates that while the stock remains under pressure, the intensity of the downtrend has somewhat eased. The current price stands at ₹1,334.85, down from the previous close of ₹1,360.05, reflecting a short-term decline. The stock’s 52-week range spans from ₹1,205.65 to ₹1,701.40, placing the current price closer to the lower end of this spectrum, which may suggest limited downside room but also highlights recent weakness. Technical Indicators: A Mixed Bag Examining the key technical indicators provides a nuanced view. The Moving Average Convergence Divergence (MACD) remains bearish on the wee...

Rainbow Childrens Medicare: Technical Momentum and Market Assessment Update

2025-12-02 08:12:38

Rainbow Childrens Medicare has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bearish and bullish signals across multiple timeframes. This article analyses the recent changes in key technical indicators and places the stock’s performance in the context of broader market trends.

Rainbow Childrens Medicare Faces Technical Momentum Shift Amid Mixed Market Signals

2025-12-01 08:05:04

Rainbow Childrens Medicare, a key player in the hospital sector, is exhibiting a notable shift in its technical momentum as recent evaluation adjustments reflect a transition from mildly bearish to bearish trends. This development comes amid a complex interplay of technical indicators, including MACD, RSI, and moving averages, which collectively paint a nuanced picture of the stock’s near-term trajectory.

Rainbow Childrens Medicare Sees Mixed Technical Signals Amid Market Shifts

2025-11-28 08:08:02

Rainbow Childrens Medicare has experienced a nuanced shift in its technical indicators, reflecting a complex momentum landscape as the stock navigates recent market conditions. While some weekly signals suggest emerging bullish tendencies, monthly trends and moving averages indicate a cautious stance for investors in the hospital sector.

Rainbow Child. Sees Revision in Market Evaluation Amid Mixed Financial Signals

2025-11-27 10:05:37

Rainbow Child., a small-cap player in the hospital sector, has experienced a revision in its market evaluation reflecting a shift in analytical perspective. This adjustment follows a detailed review of the company’s financial trends, valuation, quality, and technical outlook, highlighting challenges in long-term growth and market performance despite certain positive financial indicators.

Rainbow Childrens Medicare Q2 FY26: Strong Quarterly Rebound Masks Valuation Concerns

2025-11-15 11:00:17

Rainbow Childrens Medicare Ltd., India's specialised paediatric and multispecialty hospital chain, delivered a robust operational performance in Q2 FY26, with consolidated net profit surging 40.65% quarter-on-quarter to ₹75.25 crores. However, the year-on-year picture remains subdued, with profits declining 4.59% from ₹78.87 crores in Q2 FY25, raising questions about sustainable growth momentum. The stock, currently trading at ₹1,339.95 with a market capitalisation of ₹13,614 crores, has declined 1.08% following the results announcement, reflecting investor caution despite the sequential improvement.

How has been the historical performance of Rainbow Child.?

2025-11-15 00:27:13

Answer: The historical performance of Rainbow Child shows a consistent growth trend across various financial metrics over the past six years. Breakdown: Rainbow Child's net sales have increased significantly from 650.05 Cr in Mar'21 to 1,515.87 Cr in Mar'25, reflecting a strong upward trajectory. Total operating income followed a similar trend, rising from 719.39 Cr in Mar'20 to 1,515.87 Cr in Mar'25. The company's operating profit (PBDIT) also saw substantial growth, climbing from 173.10 Cr in Mar'21 to 540.90 Cr in Mar'25, although the operating profit margin slightly decreased from 33.07% in Mar'24 to 32.32% in Mar'25. Profit before tax rose from 55.70 Cr in Mar'21 to 330.00 Cr in Mar'25, while profit after tax increased from 39.57 Cr in Mar'21 to 244.23 Cr in Mar'25, showcasing improved profitability. The total assets of the company grew from 1,018.89 Cr in Mar'20 to 2,347.40 Cr in Mar'25, indicating a...

How has been the historical performance of Rainbow Child.?

2025-11-13 23:48:54

Answer: The historical performance of Rainbow Child shows a consistent growth trajectory over the years. Breakdown: Rainbow Child's net sales have increased significantly from INR 650.05 crore in March 2021 to INR 1,515.87 crore in March 2025, reflecting a strong upward trend. Total operating income followed suit, rising from INR 719.39 crore in March 2020 to the same INR 1,515.87 crore in March 2025. The company's operating profit (PBDIT) also saw substantial growth, climbing from INR 173.10 crore in March 2021 to INR 540.90 crore in March 2025. Profit before tax rose from INR 55.70 crore in March 2021 to INR 330.00 crore in March 2025, while profit after tax increased from INR 39.57 crore to INR 244.23 crore during the same period. The earnings per share (EPS) improved from INR 7.29 in March 2021 to INR 23.97 in March 2025, indicating enhanced shareholder value. On the balance sheet, total assets grew fr...

Are Rainbow Child. latest results good or bad?

2025-11-13 19:38:43

Rainbow Childrens Medicare has announced its financial results for the quarter ending June 2025, which reflect a mix of operational trends. The company reported an annual operating cash flow of Rs 385.05 crore, marking the highest level in the last three years, indicating a positive trend in cash revenues from its business operations. Additionally, the debt-equity ratio improved to 0.52 times, the lowest in the last five half-year periods, suggesting a reduction in borrowing relative to equity capital. The company also declared a dividend per share of Rs 3.00, the highest in five years, demonstrating a commitment to returning profits to shareholders. However, the results also highlight some challenges. Profit Before Tax (PBT) fell by 26.4% to Rs 51.35 crore, and Profit After Tax (PAT) decreased by 12.1% to Rs 53.50 crore, indicating negative trends compared to previous quarters. Net sales also declined by ...

View All News